Daniela E Oprea-Lager
Overview
Explore the profile of Daniela E Oprea-Lager including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
2874
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
van den Kroonenberg D, Stoter J, Jager A, Veerman H, Hagens M, Schoots I, et al.
Eur Urol Open Sci
. 2024 Apr;
63:13-18.
PMID: 38558763
Background And Objective: A combined approach of magnetic resonance imaging (MRI)-targeted biopsy (TBx) and bilateral systematic biopsy (SBx) is advised in patients who have an increased risk of prostate cancer...
22.
Boers J, Eisses B, Zwager M, van Geel J, Bensch F, de Vries E, et al.
Diagnostics (Basel)
. 2024 Feb;
14(4).
PMID: 38396455
Background: In metastatic breast cancer (MBC), [F]fluorodeoxyglucose positron emission tomography/computed tomography ([F]FDG-PET/CT) can be used for staging. We evaluated the correlation between BC histopathological characteristics and [F]FDG uptake in corresponding...
23.
Meijer D, van Leeuwen P, Eppinga W, Vanneste B, Meijnen P, Daniels L, et al.
Eur Urol Open Sci
. 2024 Feb;
61:37-43.
PMID: 38384437
Background And Objective: Owing to the greater use of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with biochemical recurrence (BCR) of prostate cancer (PCa) after robot-assisted...
24.
Pouw J, Hashemi S, Huisman M, Wijngaarden J, Slebe M, Oprea-Lager D, et al.
J Immunother Cancer
. 2024 Feb;
12(2).
PMID: 38302416
Background: In patients with locally advanced unresectable non-small cell lung cancer (NSCLC), durvalumab, an anti-programmed cell death ligand-1 (PD-L1) antibody, has shown improved overall survival when used as consolidation therapy...
25.
Luining W, Hagens M, Meijer D, Ringia J, de Weijer T, Bektas H, et al.
Eur Urol Open Sci
. 2024 Feb;
59:55-62.
PMID: 38298765
Background And Objectives: The association between prostate-specific antigen (PSA) level and probability of metastatic disease on prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) has not yet been established...
26.
Donswijk M, Ettema R, Meijer D, Wondergem M, Cheung Z, Bekers E, et al.
Eur J Nucl Med Mol Imaging
. 2024 Jan;
51(6):1741-1752.
PMID: 38273003
Purpose: Prostate-specific membrane antigen (PSMA) positron emission tomography/ computed tomography (PET/CT) is recognized as the most accurate imaging modality for detection of metastatic high-risk prostate cancer (PCa). Its role in...
27.
Slevin F, Zattoni F, Checcucci E, Cumberbatch M, Nacchia A, Cornford P, et al.
Eur Urol Oncol
. 2023 Dec;
7(4):677-696.
PMID: 38151440
Context: The optimum use of brachytherapy (BT) combined with external beam radiotherapy (EBRT) for localised/locally advanced prostate cancer (PCa) remains uncertain. Objective: To perform a systematic review to determine the...
28.
Luining W, Oprea-Lager D, Vis A, van Moorselaar R, Knol R, Wondergem M, et al.
PLoS One
. 2023 Nov;
18(11):e0293672.
PMID: 37943772
Introduction: Radiomics extracted from prostate-specific membrane antigen (PSMA)-PET modeled with machine learning (ML) may be used for prediction of disease risk. However, validation of previously proposed approaches is lacking. We...
29.
Staal F, Janssen J, Oprea-Lager D, Engelen A, Van Limbergen E, Smeenk R, et al.
Int J Radiat Oncol Biol Phys
. 2023 Sep;
118(3):688-696.
PMID: 37729971
Purpose: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) scan is the standard imaging procedure for biochemical recurrent prostate cancer postprostatectomy because of its high detection rate at low...
30.
van Lith S, Pruis I, Tolboom N, Snijders T, Henssen D, Laan M, et al.
J Nucl Med
. 2023 Aug;
64(10):1526-1531.
PMID: 37652540
Upregulation of prostate-specific membrane antigen (PSMA) in neovasculature has been described in glioblastoma multiforme (GBM), whereas vasculature in nonaffected brain shows hardly any expression of PSMA. It is unclear whether...